OmeCare company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

omecare.co

Founded Year

2008

Stage

Series E | Alive

Total Raised

$40M

Last Raised

$40M | 6 yrs ago

About OmeCare

OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.

OmeCare Headquarter Location

6777 Nancy Ridge Drive

San Diego, California, 92121,

United States

877-505-7374

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing OmeCare

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned OmeCare in 4 CB Insights research briefs, most recently on May 25, 2021.

Expert Collections containing OmeCare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

OmeCare is included in 6 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

8,693 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

M

Medical Devices

7,911 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

12,794 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,900 items

OmeCare Patents

OmeCare has filed 45 patents.

The 3 most popular patent topics include:

  • Computing input devices
  • 3D imaging
  • Capacitors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2017

2/15/2022

Computing input devices, Capacitors, Pointing devices, Display devices, Stationery

Grant

Application Date

12/20/2017

Grant Date

2/15/2022

Title

Related Topics

Computing input devices, Capacitors, Pointing devices, Display devices, Stationery

Status

Grant

Latest OmeCare News

OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership

Sep 28, 2021

OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership The partnership provides a turnkey approach for workplaces, schools, major conventions, and other group events looking to ensure safety and meet governmental mandates for students, staff, employees, and event participants. SAN DIEGO - September 28, 2021 - ( Newswire.com ) OmeCare and LifeSite have launched a synergistic partnership that combines COVID-19 testing with a test and vaccination status management solution for events, organizations, and companies of all sizes. The partnership provides a turnkey approach for workplaces, schools, major conventions, and other group events looking to ensure safety and meet governmental mandates for students, staff, employees, and event participants. The solution encompasses deployment, testing, and test administration, combined with fast turnaround of lab results - all viewable in real-time through a comprehensive management dashboard. As an initial screening, on-site rapid antigen tests provide patients with results within minutes, while more extensive RT-PCR testing is provided to individuals testing positive. For incoming travelers who require inbound or outbound RT-PCR testing, the joint service will provide worry-free solutions for traveling attendees onsite or at the host hotel. The partnership offers organizations with a variety of COVID-19 testing options: Antigen on-site and monitored nasal swab test: results received in 10 minutes PCR at-home saliva test: results received in 24-48 hours PCR on-site and monitored saliva test: results received in 24-48 hours A comprehensive student, attendee, employee dashboard for test results, vaccination status tracking and compliance reporting "Many customers are looking for full solutions that combine both onsite rapid antigen testing and PCR tests to ensure the highest level of compliance and safety. We are pleased to be working with the LifeSite team, who has the infrastructure, solutions, experience, and front-line staff to provide A-Z service offerings," said Hartley Miller, Chief Revenue Officer of OmeCare. "As we service schools, corporations, and events across the country, it is comforting to add OmeCare's California CLIA/CAP-accredited laboratory to our lab network," added Chris Wong, Chairman and CEO of LifeSite. OmeCare has validated a COVID-19 real-time PCR test performed by licensed laboratory scientists specially-trained in performing the COVID-19 testing. All processes are completed in a BSL-2 safety level laboratory and comply with the Centers for Disease Control and Prevention (CDC) guidelines. ###  ABOUT OMECARE OmeCare is a trusted provider of DNA testing and reporting for both clinicians and consumers, employing a renowned team of leading bioinformatics, genetic and molecular biologists, nutritionists, physicians, Al scientists, and technicians who operate in a clinical-grade, high-complexity, College of Pathologists (CAP) and Clinical Laboratory Improvements Amendment (CUA) accredited laboratory. This state-of-the-art facility has the capability of performing any type of molecular testing including next-generation sequencing (NGS), genotyping, epigenetic­ methylation, and RT-PCR/dPCR for viral identification. Visit https://omecare.com/my-health/covid-19/ for more information. ABOUT LIFESITE About LifeSite LifeSite was founded to inspire and empower people by connecting their heads and their heart - providing personal peace of mind today and for family and loved ones tomorrow. A previous "Consumers' Choice" winner at AARP Innovation@50+, LifeSite provides secure, convenient, and smart web-based solutions to help individuals, families, and trusted advisors store, organize and access the most important information in their life, anytime, anywhere. As companies faced the challenges to stay open, manage outbreaks and keep employees and their families safe, LifeSite developed a comprehensive turnkey corporate COVID testing and vaccination tracking solution: administration, sampling automation, testing, test results communication, billing, reimbursement, and secure HIPAA compliant digital storage for employee vaccination status and test results. Visit www.lifesite.co for more information. CONTACT

OmeCare Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

OmeCare Rank

You May Also Like

Color Logo
Color

Color democratizes access to genetic information. The Color Test is physician-ordered and comes with complimentary board-certified genetic counseling for clients and healthcare providers. The 30-gene Color Test analyzes genes closely associated with some of the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.

Genomelink Logo
Genomelink

Genomelink is a personal discovery platform where people store DNA data to access more insights, products, and medical researches.

ORIG3N Logo
ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based upon Nobel Prize winning technology. This will replace the trial & error guess work of treating disease and enable longer, healthier lives.

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

V
Viridis Diagnostics

Viridis' equipment is a disease marker testing platform to be used at point-of-care.

LifeNome Logo
LifeNome

LifeNome is a B2B personalized health & wellness startup that enables consumer-facing companies to personalize their products & services by generating insights from their customers’ DNA, lifestyle, and wearables data (among other sources).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.